Thank you very much for your question.
I just want to clarify. I believe--and Richard Elliott can probably correct me if I'm wrong--that Canada is actually the only country that has implemented this decision, that has included the schedule. So the schedule 1 list of medicine is not a requirement by the WTO for compliance. So we could eliminate this decision for the factors that you point out.
Research and development are happening very, very quickly. As drugs come up, we want them to be instantly available if there's a generic manufacturer who's ready to step forward and produce that drug. So we can take off this list and leave it open, and that would be compliant with our WTO obligations.